Literature DB >> 24623529

Bayesian analysis of nonlinear mixed-effects mixture models for longitudinal data with heterogeneity and skewness.

Xiaosun Lu1, Yangxin Huang.   

Abstract

It is a common practice to analyze complex longitudinal data using nonlinear mixed-effects (NLME) models with normality assumption. The NLME models with normal distributions provide the most popular framework for modeling continuous longitudinal outcomes, assuming individuals are from a homogeneous population and relying on random-effects to accommodate inter-individual variation. However, the following two issues may standout: (i) normality assumption for model errors may cause lack of robustness and subsequently lead to invalid inference and unreasonable estimates, particularly, if the data exhibit skewness and (ii) a homogeneous population assumption may be unrealistically obscuring important features of between-subject and within-subject variations, which may result in unreliable modeling results. There has been relatively few studies concerning longitudinal data with both heterogeneity and skewness features. In the last two decades, the skew distributions have shown beneficial in dealing with asymmetric data in various applications. In this article, our objective is to address the simultaneous impact of both features arisen from longitudinal data by developing a flexible finite mixture of NLME models with skew distributions under Bayesian framework that allows estimates of both model parameters and class membership probabilities for longitudinal data. Simulation studies are conducted to assess the performance of the proposed models and methods, and a real example from an AIDS clinical trial illustrates the methodology by modeling the viral dynamics to compare potential models with different distribution specifications; the analysis results are reported.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  AIDS clinical trials; Bayesian inference; longitudinal data analysis; nonlinear mixed-effects mixture models; skew distributions

Mesh:

Year:  2014        PMID: 24623529     DOI: 10.1002/sim.6136

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  A Comparison of Different Nonnormal Distributions in Growth Mixture Models.

Authors:  Sookyoung Son; Hyunjung Lee; Yoona Jang; Junyeong Yang; Sehee Hong
Journal:  Educ Psychol Meas       Date:  2019-01-24       Impact factor: 2.821

2.  Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies.

Authors:  Yangxin Huang; Xiaosun Lu; Jiaqing Chen; Juan Liang; Miriam Zangmeister
Journal:  Lifetime Data Anal       Date:  2017-10-27       Impact factor: 1.588

3.  Bayesian modeling of factorial time-course data with applications to a bone aging gene expression study.

Authors:  Joseph Wu; Mayetri Gupta; Amira I Hussein; Louis Gerstenfeld
Journal:  J Appl Stat       Date:  2020-06-01       Impact factor: 1.404

4.  Growth Mixture Modeling With Nonnormal Distributions: Implications for Data Transformation.

Authors:  Yeji Nam; Sehee Hong
Journal:  Educ Psychol Meas       Date:  2020-12-08       Impact factor: 3.088

5.  Assessing Uncertainty in A2 Respiratory Syncytial Virus Viral Dynamics.

Authors:  Gilberto González-Parra; Hana M Dobrovolny
Journal:  Comput Math Methods Med       Date:  2015-09-14       Impact factor: 2.238

6.  Early diagnosis of gestational trophoblastic neoplasia based on trajectory classification with compartment modeling.

Authors:  Claire Burny; Muriel Rabilloud; François Golfier; Jérôme Massardier; Touria Hajri; Anne-Marie Schott; Fabien Subtil
Journal:  BMC Med Res Methodol       Date:  2016-01-05       Impact factor: 4.615

7.  Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model.

Authors:  Rui Zhao; Paul Catalano; Victor G DeGruttola; Franziska Michor
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.